Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Dec;131(12):2500-3.
doi: 10.1038/jid.2011.235. Epub 2011 Aug 11.

Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population

Marianne Berwick, Colin B Begg, Bruce K Armstrong, Anne S Reiner, Nancy E Thomas, Linda S Cook, Irene Orlow, Anne Kricker, Loraine D Marrett, Stephen B Gruber, Hoda Anton-Culver, Robert C Millikan, Richard P Gallagher, Terry Dwyer, Stefano Rosso, Peter A Kanetsky, Julia Lee-Taylor
Comment

Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population

Marianne Berwick et al. J Invest Dermatol. 2011 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors state no conflict of interest.

Comment on

  • CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
    Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. Orlow I, et al. J Invest Dermatol. 2007 May;127(5):1234-43. doi: 10.1038/sj.jid.5700689. Epub 2007 Jan 11. J Invest Dermatol. 2007. PMID: 17218939

Similar articles

See all similar articles

Cited by

References

    1. Begg CB, Hummer AJ, Mujumdar U, et al. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006;35:756–64. - PubMed
    1. Begg CB, Orlow I, Hummer AJ, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst. 2005;97:1507–15. - PubMed
    1. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev. 2006;15:1520–5. - PubMed
    1. Cust AE, Harlnad M, Makalic E, et al. Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. J Med Genet. 2011;48:266–72. - PMC - PubMed
    1. Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002;94:894–903. - PubMed

Publication types

MeSH terms

Substances